Patents by Inventor Yo Mabuchi

Yo Mabuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11613733
    Abstract: A method for purifying and enriching mesenchymal stem cells (MSCs) simply and efficiently. Separation of cells expressing CD73 protein on the surface from fresh tissue isolated from a living body allows purification and enrichment of MSCs easily and efficiently. MSCs may be selectively isolated with a single antibody before culturing to establish a culture system of mesenchymal stem cells that enhances the engraftment efficiency in the transplanted site.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: March 28, 2023
    Assignees: Medical & Biological Laboratories Co., Ltd., JSR Corporation
    Inventors: Chihiro Akazawa, Eriko Grace Suto, Yo Mabuchi
  • Patent number: 11441123
    Abstract: The present invention aims to obtain a method for quality evaluation of human mesenchymal stem cells, a method for isolation, selection and culture of human mesenchymal stem cells, a cell population of rapidly proliferating human mesenchymal stem cells, as well as monoclonal antibodies that specifically recognize rapidly proliferating human mesenchymal stem cells. From a cell population containing human mesenchymal stem cells, rapidly proliferating human mesenchymal stem cells are isolated, selected and cultured. The abundance ratio of cells expressing Ror2 or Fzd5 in the cell population thus isolated, selected and cultured is quantified to determine whether or not each cell population is acceptable.
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: September 13, 2022
    Assignee: PUREC CO., LTD.
    Inventors: Yumi Iyoku, Hideyuki Okano, Yo Mabuchi
  • Publication number: 20210230553
    Abstract: The present invention aims to obtain a method for quality evaluation of human mesenchymal stem cells, a method for isolation, selection and culture of human mesenchymal stem cells, a cell population of rapidly proliferating human mesenchymal stem cells, as well as monoclonal antibodies that specifically recognize rapidly proliferating human mesenchymal stem cells. From a cell population containing human mesenchymal stem cells, rapidly proliferating human mesenchymal stem cells are isolated, selected and cultured. The abundance ratio of cells expressing Ror2 or Fzd5 in the cell population thus isolated, selected and cultured is quantified to determine whether or not each cell population is acceptable.
    Type: Application
    Filed: March 2, 2021
    Publication date: July 29, 2021
    Applicant: PUREC CO., LTD.
    Inventors: Yumi IYOKU, Hideyuki OKANO, Yo MABUCHI
  • Publication number: 20200239849
    Abstract: A method for purifying and enriching mesenchymal stem cells (MSCs) simply and efficiently. Separation of cells expressing CD73 protein on the surface from fresh tissue isolated from a living body allows purification and enrichment of MSCs easily and efficiently. MSCs may be selectively isolated with a single antibody before culturing to establish a culture system of mesenchymal stem cells that enhances the engraftment efficiency in the transplanted site.
    Type: Application
    Filed: May 11, 2018
    Publication date: July 30, 2020
    Inventors: Chihiro AKAZAWA, Eriko Grace SUTO, Yo MABUCHI
  • Publication number: 20170204374
    Abstract: The present invention aims to obtain a method for quality evaluation of human mesenchymal stem cells, a method for isolation, selection and culture of human mesenchymal stem cells, a cell population of rapidly proliferating human mesenchymal stem cells, as well as monoclonal antibodies that specifically recognize rapidly proliferating human mesenchymal stem cells. From a cell population containing human mesenchymal stem cells, rapidly proliferating human mesenchymal stem cells are isolated, selected and cultured. The abundance ratio of cells expressing Ror2 or Fzd5 in the cell population thus isolated, selected and cultured is quantified to determine whether or not each cell population is acceptable.
    Type: Application
    Filed: July 31, 2015
    Publication date: July 20, 2017
    Applicant: PUREC CO., LTD.
    Inventors: Yumi IYOKU, Hideyuki OKANO, Yo MABUCHI
  • Publication number: 20110053183
    Abstract: The present invention is intended to provide methods for highly enriching human mesenchymal stem cells from a cell population containing the human mesenchymal stem cells. To highly enrich human mesenchymal stem cells, CD271+CD90+ cells are recovered by using flow cytometry etc. from a cell population containing the human mesenchymal stem cells. If the cell population contains blood cells (as in the case of a cell population prepared from a bone marrow, a peripheral blood etc.), CD45?CD235a?CD271+CD90+ cells are recovered. These cell fractions contain with high purity the mesenchymal stem cells having self-renewal capability, self-replicating capability and pluripotency. Therefore, human mesenchymal stem cells can be highly enriched by recovering CD271+CD90+ cells from the cell population containing the human mesenchymal stem cells.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 3, 2011
    Inventors: Yumi Matsuzaki, Yo Mabuchi, Satoru Morikawa, Hideyuki Okano